Latest Restructuring News

Noble Helium has successfully renegotiated key debt facilities and raised over $3.8 million in new funding, setting the stage for a pivotal drilling campaign in Tanzania’s North Rukwa helium project in 2026.

Argent BioPharma has restructured its acquisition of AusCann assets to sharpen its clinical focus and secured a substantial A$11 million financing facility, positioning itself for growth in 2026.

Aurora Labs has marked a significant milestone by securing its first purchase order for micro gas turbine engines, alongside strategic MOUs with major defence groups and a $5.5 million capital raise to fuel growth.

MCS Services Limited reported steady operations and positive cash flow for the December 2025 quarter while progressing the sale of its Highways Traffic subsidiary to Altus Traffic, pending shareholder approval.

Nexion Group has completed the sale of its Networks businesses and is pivoting to focus on data centre operations and its FuseAI software platform, preparing for an ASX relisting.

NT Minerals faces ASX trading suspension but pushes forward with exploration plans at Twin Peaks and Finniss River projects, while considering capital restructuring.

Energy Technologies Limited has significantly improved its cash flow position in the December 2025 quarter, reducing cash outflows by over a third while raising additional debt funding to support working capital.

Anagenics Limited reports a significant turnaround with profitable trading in the second quarter of FY26, driven by strong brand performance and a successful capital raise. The company is poised for growth with expanding product lines and international ambitions.

Knosys reports steady revenue growth and a strategic partnership to upgrade its GreenOrbit platform, while accelerating development of its AI-powered Libero X library solution for a global launch next year.

SRJ Technologies has completed the first phase of its growth strategy and is now advancing into market penetration with a significant $23.8 million joint venture in the Middle East and a key board appointment.

Freedom Care Group Holdings reports a modest cash increase to $0.5 million but continues to grapple with delayed payments from the NDIA, while exploring options to relist on the ASX.

Freedom Care Group Holdings has revealed ongoing financial distress with key subsidiaries entering liquidation and persistent delays in payments from the NDIA, leaving the company with a diminished cash reserve and a strategic focus on asset sales and cost reduction.